Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00190905 · ClinicalTrials.gov registry record · Phase 4
Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 4,000
- Enrollment target
NCT00190905: Completed Phase 4 study, sponsored by Eli Lilly and Company.
NCT00190905 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 4,000 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (672% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00190905, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 4,000 participants
- Enrollment target
Study Summary
The purpose of the trial is to study the safety and effectiveness of duloxetine HCl in women of different backgrounds with stress urinary incontinence who may also have other various medical conditions.
Interventions
- DRUG duloxetine HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2004-02 |
| Est. Completion | 2005-07 |
| Phase | Phase 4 |
What the finished NCT00190905 record still lists
NCT00190905 is an interventional study that assigns participants to a tested intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (672% higher).
The record links to 0 conditions, and to 1 intervention - of which duloxetine HCl is the first listed.
NCT00190905 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00190905 about?
NCT00190905 is a clinical study titled "Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.". The purpose of the trial is to study the safety and effectiveness of duloxetine HCl in women of different backgrounds with stress urinary incontinence who may also have other various medical conditions.
What is the current status of trial NCT00190905?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 4,000 participants. The study started on 2004-02. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00190905?
The interventions under investigation include: duloxetine HCl (DRUG).
Who is sponsoring clinical trial NCT00190905?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00190905's enrollment target sits among peer trials
4,000 20th of 2000 higher than 1,980 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia